tiprankstipranks
Advertisement
Advertisement
Lisata Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyLisata Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
Lisata Therapeutics Amends Kuva Labs Merger Agreement Timeline
Premium
Company Announcements
Lisata Therapeutics Amends Kuva Labs Merger Agreement Timeline
2M ago
Lisata Therapeutics extends deadline for Kuva tender offer
Premium
Company Announcements
Lisata Therapeutics extends deadline for Kuva tender offer
2M ago
Is LSTA a Buy, Before Earnings?
PremiumPre-EarningsIs LSTA a Buy, Before Earnings?
4M ago
Lisata Therapeutics ends Qilu certepetide collaboration deal
Premium
Company Announcements
Lisata Therapeutics ends Qilu certepetide collaboration deal
5M ago
Lisata Therapeutics announces mutual termination of license agreement with Qilu
Premium
The Fly
Lisata Therapeutics announces mutual termination of license agreement with Qilu
5M ago
Lisata Therapeutics Reports Positive Q3 2025 Results
PremiumCompany AnnouncementsLisata Therapeutics Reports Positive Q3 2025 Results
8M ago
Lisata Therapeutics Reports Q3 Results and Strategic Alliances
Premium
Company Announcements
Lisata Therapeutics Reports Q3 Results and Strategic Alliances
8M ago
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
Premium
The Fly
Lisata Therapeutics highlights iRGD cyclic peptide product candidate data
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100